TY - STD TI - Aldridge BB, Burke JM, Lauffenburger D a, Sorger PK. Physicochemical modelling of cell signalling pathways. Nat Cell Biol 2006;8(11):1195–1203. ID - ref1 ER - TY - JOUR AU - Alessi, D. R. AU - James, S. R. AU - Downes, C. P. AU - Holmes, A. B. AU - Gaffney, P. R. AU - Reese, C. B. PY - 1997 DA - 1997// TI - Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha JO - Curr Biol VL - 7 UR - https://doi.org/10.1016/S0960-9822(06)00122-9 DO - 10.1016/S0960-9822(06)00122-9 ID - Alessi1997 ER - TY - STD TI - Alon U. An introduction to systems biology: design principles of biological circuits: CRC press; 2006. https://www.crcpress.com/An-Introduction-to-Systems-Biology-Design-Principles-of-Biological-Circuits/Alon/p/book/9781584886426 UR - https://www.crcpress.com/An-Introduction-to-Systems-Biology-Design-Principles-of-Biological-Circuits/Alon/p/book/9781584886426 ID - ref3 ER - TY - STD TI - Anderson GR, Wardell SE, Cakir M, Crawford L, Leeds JC, Nussbaum DP, et al. PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation 2016;175(December):1–15. ID - ref4 ER - TY - JOUR AU - André, F. AU - Cortés, J. PY - 2015 DA - 2015// TI - Rationale for targeting fibroblast growth factor receptor signaling in breast cancer JO - Breast Cancer Res Treat VL - 150 UR - https://doi.org/10.1007/s10549-015-3301-y DO - 10.1007/s10549-015-3301-y ID - André2015 ER - TY - JOUR AU - Archer, T. C. AU - Fertig, E. J. AU - Gosline, S. J. C. AU - Hafner, M. AU - Hughes, S. K. AU - Joughin, B. A. PY - 2016 DA - 2016// TI - Systems Approaches to Cancer Biology JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-16-1580 DO - 10.1158/0008-5472.CAN-16-1580 ID - Archer2016 ER - TY - JOUR AU - Bosch, A. AU - Li, Z. AU - Bergamaschi, A. AU - Ellis, H. AU - Toska, E. AU - Prat, A. PY - 2015 DA - 2015// TI - PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor – positive breast cancer JO - Sci Transl VL - 7 UR - https://doi.org/10.1126/scitranslmed.aaa4442 DO - 10.1126/scitranslmed.aaa4442 ID - Bosch2015 ER - TY - JOUR AU - Box, G. E. P. PY - 1976 DA - 1976// TI - Science and statistics JO - J Am Stat Assoc VL - 71 UR - https://doi.org/10.1080/01621459.1976.10480949 DO - 10.1080/01621459.1976.10480949 ID - Box1976 ER - TY - JOUR AU - Box, G. E. P. PY - 1979 DA - 1979// TI - Robustness in the strategy of scientific model building. Robustness JO - Stat VL - 1 ID - Box1979 ER - TY - JOUR AU - Burra, P. V. AU - Zhang, Y. AU - Godzik, A. AU - Stec, B. PY - 2009 DA - 2009// TI - Global distribution of conformational states derived from redundant models in the PDB points to non-uniqueness of the protein structure JO - Proc Natl Acad Sci U S A VL - 106 UR - https://doi.org/10.1073/pnas.0812152106 DO - 10.1073/pnas.0812152106 ID - Burra2009 ER - TY - JOUR AU - Carracedo, A. AU - Ma, L. AU - Teruya-feldstein, J. AU - Rojo, F. AU - Salmena, L. PY - 2008 DA - 2008// TI - Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K- dependent feedback loop in human cancer JO - J Clin Invest VL - 118 ID - Carracedo2008 ER - TY - JOUR AU - Castel, P. AU - Ellis, H. AU - Bago, R. AU - Toska, E. AU - Razavi, P. AU - Carmona, F. J. PY - 2016 DA - 2016// TI - PDK1-SGK1 signaling sustains AKT-independent mTORC1 activation and confers resistance to PI3Kα inhibition JO - Cancer Cell VL - 30 UR - https://doi.org/10.1016/j.ccell.2016.06.004 DO - 10.1016/j.ccell.2016.06.004 ID - Castel2016 ER - TY - JOUR AU - Castellano, E. AU - Downward, J. R. A. S. PY - 2011 DA - 2011// TI - Interaction with PI3K: more than just another effector pathway JO - Genes Cancer VL - 2 UR - https://doi.org/10.1177/1947601911408079 DO - 10.1177/1947601911408079 ID - Castellano2011 ER - TY - JOUR AU - Chakrabarty, A. AU - Sanchez, V. AU - Kuba, M. G. AU - Rinehart, C. AU - Arteaga, C. L. PY - 2012 DA - 2012// TI - Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors JO - Proc Natl Acad Sci VL - 109 UR - https://doi.org/10.1073/pnas.1018001108 DO - 10.1073/pnas.1018001108 ID - Chakrabarty2012 ER - TY - JOUR AU - Chandarlapaty, S. AU - Sawai, A. AU - Scaltriti, M. AU - Rodrik-Outmezguine, V. AU - Grbovic-Huezo, O. AU - Serra, V. PY - 2011 DA - 2011// TI - AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity JO - Cancer Cell VL - 19 UR - https://doi.org/10.1016/j.ccr.2010.10.031 DO - 10.1016/j.ccr.2010.10.031 ID - Chandarlapaty2011 ER - TY - JOUR AU - Ciriello, G. AU - Gatza, M. L. AU - Beck, A. H. AU - Wilkerson, M. D. AU - Rhie, S. K. AU - Pastore, A. PY - 2015 DA - 2015// TI - Comprehensive molecular portraits of invasive lobular breast cancer JO - Cell VL - 163 UR - https://doi.org/10.1016/j.cell.2015.09.033 DO - 10.1016/j.cell.2015.09.033 ID - Ciriello2015 ER - TY - STD TI - Cohen O, Kim D, Oh C, Waks A, Oliver N, Helvie K, et al. Abstract S1-01: whole exome and transcriptome sequencing of resistant ER+ metastatic breast cancer. Cancer Res 2017 ;77(4 Supplement):S1-1-S1-1. ID - ref17 ER - TY - JOUR AU - Collombet, S. AU - van Oevelen, C. AU - Sardina Ortega, J. L. AU - Abou-Jaoudé, W. AU - Di Stefano, B. AU - Thomas-Chollier, M. PY - 2017 DA - 2017// TI - Logical modeling of lymphoid and myeloid cell specification and transdifferentiation JO - Proc Natl Acad Sci VL - 114 UR - https://doi.org/10.1073/pnas.1610622114 DO - 10.1073/pnas.1610622114 ID - Collombet2017 ER - TY - JOUR AU - Costa, C. AU - Ebi, H. AU - Martini, M. AU - Beausoleil, S. A. AU - Faber, A. C. AU - Jakubik, C. T. PY - 2015 DA - 2015// TI - Measurement of PIP3 levels reveals an unexpected role for p110β in early adaptive responses to p110α-specific inhibitors in luminal breast cancer JO - Cancer Cell VL - 27 UR - https://doi.org/10.1016/j.ccell.2014.11.007 DO - 10.1016/j.ccell.2014.11.007 ID - Costa2015 ER - TY - JOUR AU - Cree, I. A. AU - Charlton, P. PY - 2017 DA - 2017// TI - Molecular chess? Hallmarks of anti-cancer drug resistance JO - BMC Cancer VL - 17 UR - https://doi.org/10.1186/s12885-016-2999-1 DO - 10.1186/s12885-016-2999-1 ID - Cree2017 ER - TY - JOUR AU - CURRIE, R. A. AU - WALKER, K. S. AU - GRAY, A. AU - DEAK, M. AU - CASAMAYOR, A. AU - DOWNES, C. P. PY - 1999 DA - 1999// TI - Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1 JO - Biochem J VL - 337 UR - https://doi.org/10.1042/bj3370575 DO - 10.1042/bj3370575 ID - CURRIE1999 ER - TY - JOUR AU - Ebi, H. AU - Costa, C. AU - Faber, A. C. AU - Nishtala, M. AU - Kotani, H. AU - Juric, D. PY - 2013 DA - 2013// TI - PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1 JO - Proc Natl Acad Sci U S A VL - 110 UR - https://doi.org/10.1073/pnas.1314124110 DO - 10.1073/pnas.1314124110 ID - Ebi2013 ER - TY - JOUR AU - Elkabets, M. AU - Vora, S. AU - Juric, D. AU - Morse, N. AU - Mino-Kenudson, M. AU - Muranen, T. PY - 2013 DA - 2013// TI - mTORC1 inhibition is required for sensitivity to PI3K p110alpha inhibitors in PIK3CA-mutant breast cancer JO - Sci Transl Med VL - 5 UR - https://doi.org/10.1126/scitranslmed.3005747 DO - 10.1126/scitranslmed.3005747 ID - Elkabets2013 ER - TY - JOUR AU - Finn, R. S. AU - Dering, J. AU - Conklin, D. AU - Kalous, O. AU - Cohen, D. J. AU - Desai, A. J. PY - 2009 DA - 2009// TI - PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro JO - Breast Cancer Res VL - 11 UR - https://doi.org/10.1186/bcr2419 DO - 10.1186/bcr2419 ID - Finn2009 ER - TY - JOUR AU - Friedman, A. A. AU - Letai, A. AU - Fisher, D. E. AU - Flaherty, K. T. PY - 2015 DA - 2015// TI - Precision medicine for cancer with next-generation functional diagnostics JO - Nat Rev Cancer VL - 15 UR - https://doi.org/10.1038/nrc4015 DO - 10.1038/nrc4015 ID - Friedman2015 ER - TY - JOUR AU - Garg, A. AU - Di Cara, A. AU - Xenarios, I. AU - Mendoza, L. AU - De Micheli, G. PY - 2008 DA - 2008// TI - Synchronous versus asynchronous modeling of gene regulatory networks JO - Bioinformatics VL - 24 UR - https://doi.org/10.1093/bioinformatics/btn336 DO - 10.1093/bioinformatics/btn336 ID - Garg2008 ER - TY - STD TI - Garraway LA, Jänne PA. Circumventing cancer drug resistance in the era of personalized medicine. Cancer Discovery. 2012;2:214–26. ID - ref27 ER - TY - JOUR AU - Higgins, M. J. AU - Baselga, J. PY - 2011 DA - 2011// TI - Targeted therapies for breast cancer JO - J Clin Invest VL - 121 UR - https://doi.org/10.1172/JCI57152 DO - 10.1172/JCI57152 ID - Higgins2011 ER - TY - JOUR AU - Holohan, C. AU - Van Schaeybroeck, S. AU - Longley, D. B. AU - Johnston, P. G. PY - 2013 DA - 2013// TI - Cancer drug resistance: an evolving paradigm JO - Nat Rev Cancer VL - 13 UR - https://doi.org/10.1038/nrc3599 DO - 10.1038/nrc3599 ID - Holohan2013 ER - TY - JOUR AU - Hui, R. AU - Finney, G. L. AU - Carroll, J. S. AU - Lee, C. S. L. AU - Musgrove, E. A. AU - Sutherland, R. L. PY - 2002 DA - 2002// TI - Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells JO - Cancer Res VL - 62 ID - Hui2002 ER - TY - JOUR AU - Johannessen, C. M. AU - Boehm, J. S. PY - 2017 DA - 2017// TI - Progress towards precision functional genomics JO - Curr Opin Syst Biol VL - 2 UR - https://doi.org/10.1016/j.coisb.2017.02.002 DO - 10.1016/j.coisb.2017.02.002 ID - Johannessen2017 ER - TY - JOUR AU - Juric, D. AU - Castel, P. AU - Griffith, M. AU - Griffith, O. L. AU - Won, H. H. AU - Ellis, H. PY - 2015 DA - 2015// TI - Convergent loss of PTEN leads to clinical resistance to a PI(3)Kalpha inhibitor JO - Nature VL - 518 UR - https://doi.org/10.1038/nature13948 DO - 10.1038/nature13948 ID - Juric2015 ER - TY - JOUR AU - Kapuy, O. AU - Barik, D. AU - Domingo Sananes, M. R. AU - Tyson, J. J. AU - Novák, B. PY - 2009 DA - 2009// TI - Bistability by multiple phosphorylation of regulatory proteins JO - Prog Biophys Mol Biol VL - 100 UR - https://doi.org/10.1016/j.pbiomolbio.2009.06.004 DO - 10.1016/j.pbiomolbio.2009.06.004 ID - Kapuy2009 ER - TY - JOUR AU - Klamt, S. AU - Saez-Rodriguez, J. AU - Lindquist, J. A. AU - Simeoni, L. AU - Gilles, E. D. A. PY - 2006 DA - 2006// TI - Methodology for the structural and functional analysis of signaling and regulatory networks JO - BMC Bioinformatics VL - 7 UR - https://doi.org/10.1186/1471-2105-7-56 DO - 10.1186/1471-2105-7-56 ID - Klamt2006 ER - TY - JOUR AU - Koboldt, D. C. AU - Fulton, R. S. AU - McLellan, M. D. AU - Schmidt, H. AU - Kalicki-Veizer, J. AU - McMichael, J. F. PY - 2012 DA - 2012// TI - Comprehensive molecular portraits of human breast tumours JO - Nature VL - 490 UR - https://doi.org/10.1038/nature11412 DO - 10.1038/nature11412 ID - Koboldt2012 ER - TY - JOUR AU - Kodack, D. P. AU - Askoxylakis, V. AU - Ferraro, G. B. AU - Sheng, Q. AU - Badeaux, M. AU - Goel, S. PY - 2017 DA - 2017// TI - The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation JO - Sci Transl Med VL - 9 UR - https://doi.org/10.1126/scitranslmed.aal4682 DO - 10.1126/scitranslmed.aal4682 ID - Kodack2017 ER - TY - JOUR AU - Kumar Jolly, M. AU - Levine, H. PY - 2017 DA - 2017// TI - Computational systems biology of epithelial-hybrid- mesenchymal transitions. Curr Opin JO - Syst Biol VL - 3 ID - Kumar Jolly2017 ER - TY - JOUR AU - Le, X. AU - Antony, R. AU - Razavi, P. AU - Treacy, D. J. AU - Luo, F. AU - Ghandi, M. PY - 2016 DA - 2016// TI - Systematic functional characterization of resistance to PI3K inhibition in breast cancer JO - Cancer Discov. VL - 6 UR - https://doi.org/10.1158/2159-8290.CD-16-0305 DO - 10.1158/2159-8290.CD-16-0305 ID - Le2016 ER - TY - JOUR AU - Lee, M. J. AU - Ye, A. S. AU - Gardino, A. K. AU - Heijink, A. M. AU - Sorger, P. K. AU - MacBeath, G. PY - 2012 DA - 2012// TI - Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks JO - Cell VL - 149 UR - https://doi.org/10.1016/j.cell.2012.03.031 DO - 10.1016/j.cell.2012.03.031 ID - Lee2012 ER - TY - JOUR AU - Lim, K. H. AU - Counter, C. M. PY - 2005 DA - 2005// TI - Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance JO - Cancer Cell VL - 8 UR - https://doi.org/10.1016/j.ccr.2005.10.014 DO - 10.1016/j.ccr.2005.10.014 ID - Lim2005 ER - TY - STD TI - Mao P, Quartey Q, Cohen O, Piccioni F, Wagle N. Abstract P3-03-08: a large-scale functional screen to identify resistance mechanisms to selective estrogen receptor degraders fulvestrant and GDC-810 in ER+ breast cancer. Cancer Res 2017 ;77(4 Supplement):P3-3-8-P3-03–8. ID - ref41 ER - TY - JOUR AU - Massarweh, S. AU - Osborne, C. K. AU - Creighton, C. J. AU - Qin, L. AU - Tsimelzon, A. AU - Huang, S. PY - 2008 DA - 2008// TI - Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-2707 DO - 10.1158/0008-5472.CAN-07-2707 ID - Massarweh2008 ER - TY - JOUR AU - Mayer, I. A. AU - Arteaga, C. L. PY - 2016 DA - 2016// TI - The PI3K/AKT pathway as a target for cancer treatment JO - Annu Rev Med VL - 67 UR - https://doi.org/10.1146/annurev-med-062913-051343 DO - 10.1146/annurev-med-062913-051343 ID - Mayer2016 ER - TY - JOUR AU - Méndez-López, L. F. AU - Davila-Velderrain, J. AU - Domínguez-Hüttinger, E. AU - Enríquez-Olguín, C. AU - Martínez-García, J. C. AU - Alvarez-Buylla, E. R. PY - 2017 DA - 2017// TI - Gene regulatory network underlying the immortalization of epithelial cells JO - BMC Syst Biol VL - 11 UR - https://doi.org/10.1186/s12918-017-0393-5 DO - 10.1186/s12918-017-0393-5 ID - Méndez-López2017 ER - TY - JOUR AU - Meric-Bernstam, F. AU - Mills, G. B. PY - 2012 DA - 2012// TI - Overcoming implementation challenges of personalized cancer therapy JO - Nat Rev Clin Oncol VL - 9 UR - https://doi.org/10.1038/nrclinonc.2012.127 DO - 10.1038/nrclinonc.2012.127 ID - Meric-Bernstam2012 ER - TY - JOUR AU - Miller, T. W. AU - Balko, J. M. AU - Fox, E. M. AU - Ghazoui, Z. AU - Dunbier, A. AU - Anderson, H. PY - 2011 DA - 2011// TI - ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer JO - Cancer Discov VL - 1 UR - https://doi.org/10.1158/2159-8290.CD-11-0101 DO - 10.1158/2159-8290.CD-11-0101 ID - Miller2011 ER - TY - JOUR AU - Miller, T. W. AU - Hennessy, B. T. AU - González-Angulo, A. M. AU - Fox, E. M. AU - Mills, G. B. AU - Chen, H. PY - 2010 DA - 2010// TI - Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer JO - J Clin Invest VL - 120 UR - https://doi.org/10.1172/JCI41680 DO - 10.1172/JCI41680 ID - Miller2010 ER - TY - JOUR AU - Milo, R. AU - Jorgensen, P. AU - Moran, U. AU - Weber, G. AU - Springer, M. PY - 2010 DA - 2010// TI - BioNumbers—the database of key numbers in molecular and cell biology JO - Nucleic Acids Res VL - 38 UR - https://doi.org/10.1093/nar/gkp889 DO - 10.1093/nar/gkp889 ID - Milo2010 ER - TY - STD TI - Milo R, Phillips R. Cell biology by the numbers: Garland Science; 2015. http://garlandscience.com/product/isbn/9780815345374 UR - http://garlandscience.com/product/isbn/9780815345374 ID - ref49 ER - TY - JOUR AU - Morris, M. K. AU - Saez-Rodriguez, J. AU - Sorger, P. K. AU - Lauffenburger, D. A. PY - 2010 DA - 2010// TI - Logic-based models for the analysis of cell signaling networks JO - Biochemistry VL - 49 UR - https://doi.org/10.1021/bi902202q DO - 10.1021/bi902202q ID - Morris2010 ER - TY - JOUR AU - Muellner, M. K. AU - Uras, I. Z. AU - Gapp, B. V. AU - Kerzendorfer, C. AU - Smida, M. AU - Lechtermann, H. PY - 2011 DA - 2011// TI - A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer JO - Nat Chem Biol VL - 7 UR - https://doi.org/10.1038/nchembio.695 DO - 10.1038/nchembio.695 ID - Muellner2011 ER - TY - JOUR AU - Musgrove, E. A. AU - Sutherland, R. L. PY - 2009 DA - 2009// TI - Biological determinants of endocrine resistance in breast cancer JO - Nat Rev Cancer VL - 9 UR - https://doi.org/10.1038/nrc2713 DO - 10.1038/nrc2713 ID - Musgrove2009 ER - TY - JOUR AU - Nahta, R. AU - Yuan, L. X. H. AU - Zhang, B. AU - Kobayashi, R. AU - Esteva, F. J. PY - 2005 DA - 2005// TI - Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-3841 DO - 10.1158/0008-5472.CAN-04-3841 ID - Nahta2005 ER - TY - JOUR AU - O’Leary, B. AU - Finn, R. S. AU - Turner, N. C. PY - 2016 DA - 2016// TI - Treating cancer with selective CDK4/6 inhibitors JO - Nat Rev Clin Oncol VL - 13 UR - https://doi.org/10.1038/nrclinonc.2016.26 DO - 10.1038/nrclinonc.2016.26 ID - O’Leary2016 ER - TY - JOUR AU - O’Reilly, K. E. AU - Rojo, F. AU - She, Q. B. AU - Solit, D. AU - Mills, G. B. AU - Smith, D. PY - 2006 DA - 2006// TI - mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-2925 DO - 10.1158/0008-5472.CAN-05-2925 ID - O’Reilly2006 ER - TY - JOUR AU - Pereira, B. AU - Chin, S. -. F. AU - Rueda, O. M. AU - H-KM, V. AU - Provenzano, E. AU - Bardwell, H. A. PY - 2016 DA - 2016// TI - The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes JO - Nat Commun VL - 7 UR - https://doi.org/10.1038/ncomms11479 DO - 10.1038/ncomms11479 ID - Pereira2016 ER - TY - JOUR AU - Rodrik-Outmezguine, V. S. AU - Chandarlapaty, S. AU - Pagano, N. C. AU - Poulikakos, P. I. AU - Scaltriti, M. AU - Moskatel, E. PY - 2011 DA - 2011// TI - mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling JO - Cancer Discov. VL - 1 UR - https://doi.org/10.1158/2159-8290.CD-11-0085 DO - 10.1158/2159-8290.CD-11-0085 ID - Rodrik-Outmezguine2011 ER - TY - JOUR AU - Saadatpour, A. AU - Albert, I. AU - Albert, R. PY - 2010 DA - 2010// TI - Attractor analysis of asynchronous Boolean models of signal transduction networks JO - J Theor Biol VL - 266 UR - https://doi.org/10.1016/j.jtbi.2010.07.022 DO - 10.1016/j.jtbi.2010.07.022 ID - Saadatpour2010 ER - TY - JOUR AU - Saadatpour, A. AU - Albert, R. AU - Reluga, T. C. PY - 2013 DA - 2013// TI - A reduction method for Boolean network models proven to conserve attractors JO - SIAM J Appl Dyn Syst VL - 12 UR - https://doi.org/10.1137/13090537X DO - 10.1137/13090537X ID - Saadatpour2013 ER - TY - JOUR AU - Sarbassov, D. D. AU - Guertin, D. A. AU - Ali, S. M. AU - Sabatini, D. M. PY - 2005 DA - 2005// TI - Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex JO - Science VL - 307 UR - https://doi.org/10.1126/science.1106148 DO - 10.1126/science.1106148 ID - Sarbassov2005 ER - TY - JOUR AU - Sarosiek, K. A. AU - Fraser, C. AU - Muthalagu, N. AU - Bhola, P. D. AU - Chang, W. AU - McBrayer, S. K. PY - 2017 DA - 2017// TI - Developmental regulation of mitochondrial apoptosis by c-Myc governs age- and tissue-specific sensitivity to cancer therapeutics JO - Cancer Cell VL - 31 UR - https://doi.org/10.1016/j.ccell.2016.11.011 DO - 10.1016/j.ccell.2016.11.011 ID - Sarosiek2017 ER - TY - JOUR AU - Serra, V. AU - Scaltriti, M. AU - Prudkin, L. AU - Eichhorn, P. J. AU - Ibrahim, Y. H. AU - Chandarlapaty, S. PY - 2011 DA - 2011// TI - PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer JO - Oncogene VL - 30 UR - https://doi.org/10.1038/onc.2010.626 DO - 10.1038/onc.2010.626 ID - Serra2011 ER - TY - JOUR AU - Steinway, S. N. AU - Zanudo, J. G. T. AU - Ding, W. AU - Rountree, C. B. AU - Feith, D. J. AU - Loughran, T. P. PY - 2014 DA - 2014// TI - Network modeling of TGFβ signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-0225 DO - 10.1158/0008-5472.CAN-14-0225 ID - Steinway2014 ER - TY - JOUR AU - Stephens, P. J. AU - Tarpey, P. S. AU - Davies, H. AU - Van Loo, P. AU - Greenman, C. AU - Wedge, D. C. PY - 2012 DA - 2012// TI - The landscape of cancer genes and mutational processes in breast cancer JO - Nature VL - 486 ID - Stephens2012 ER - TY - JOUR AU - Tian, X. AU - Huang, B. AU - Zhang, X. -. P. AU - Lu, M. AU - Liu, F. AU - Onuchic, J. N. PY - 2017 DA - 2017// TI - Modeling the response of a tumor-suppressive network to mitogenic and oncogenic signals JO - Proc Natl Acad Sci VL - 114 UR - https://doi.org/10.1073/pnas.1702412114 DO - 10.1073/pnas.1702412114 ID - Tian2017 ER - TY - STD TI - Toska E, Osmanbeyoglu HU, Castel P, Chan C, Hendrickson RC, Elkabets M, et al. PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D. 2017;355(6331):1324–30. ID - ref66 ER - TY - JOUR AU - Turke, A. B. AU - Song, Y. AU - Costa, C. AU - Cook, R. AU - Arteaga, C. L. AU - Asara, J. M. PY - 2012 DA - 2012// TI - MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-3747 DO - 10.1158/0008-5472.CAN-11-3747 ID - Turke2012 ER - TY - JOUR AU - Turner, N. AU - Pearson, A. AU - Sharpe, R. AU - Lambros, M. AU - Geyer, F. AU - Lopez-Garcia, M. A. PY - 2010 DA - 2010// TI - FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-3746 DO - 10.1158/0008-5472.CAN-09-3746 ID - Turner2010 ER - TY - JOUR AU - Tyson, J. J. AU - Baumann, W. T. AU - Chen, C. AU - Verdugo, A. AU - Tavassoly, I. AU - Wang, Y. PY - 2011 DA - 2011// TI - Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells JO - Nat Rev Cancer VL - 11 UR - https://doi.org/10.1038/nrc3081 DO - 10.1038/nrc3081 ID - Tyson2011 ER - TY - JOUR AU - Udyavar, A. R. AU - Wooten, D. J. AU - Hoeksema, M. AU - Bansal, M. AU - Califano, A. AU - Estrada, L. PY - 2017 DA - 2017// TI - Novel hybrid phenotype revealed in small cell lung cancer by a transcription factor network model that can explain tumor heterogeneity JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-1467 DO - 10.1158/0008-5472.CAN-16-1467 ID - Udyavar2017 ER - TY - JOUR AU - Vasudevan, K. M. AU - Barbie, D. A. AU - Davies, M. A. AU - Rabinovsky, R. AU - McNear, C. J. AU - Kim, J. J. PY - 2009 DA - 2009// TI - AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer JO - Cancer Cell VL - 16 UR - https://doi.org/10.1016/j.ccr.2009.04.012 DO - 10.1016/j.ccr.2009.04.012 ID - Vasudevan2009 ER - TY - JOUR AU - Veliz-Cuba, A. AU - Aguilar, B. AU - Hinkelmann, F. AU - Laubenbacher, R. PY - 2014 DA - 2014// TI - Steady state analysis of Boolean molecular network models via model reduction and computational algebra JO - BMC Bioinformatics. VL - 15 UR - https://doi.org/10.1186/1471-2105-15-221 DO - 10.1186/1471-2105-15-221 ID - Veliz-Cuba2014 ER - TY - JOUR AU - Vora, S. AU - Juric, D. AU - Kim, N. AU - Mino-Kenudson, M. AU - Huynh, T. AU - Costa, C. PY - 2014 DA - 2014// TI - CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors JO - Cancer Cell VL - 26 UR - https://doi.org/10.1016/j.ccr.2014.05.020 DO - 10.1016/j.ccr.2014.05.020 ID - Vora2014 ER - TY - JOUR AU - Wagle, N. AU - Painter, C. AU - Anastasio, E. AU - Dunphy, M. AU - McGillicuddy, M. AU - Kim, D. PY - 2017 DA - 2017// TI - The Metastatic Breast Cancer (MBC) project: Accelerating translational research through direct patient engagement JO - J Clin Oncol VL - 35 ID - Wagle2017 ER - TY - JOUR AU - Wang, R. -. S. AU - Saadatpour, A. AU - Albert, R. PY - 2012 DA - 2012// TI - Boolean modeling in systems biology: an overview of methodology and applications JO - Phys Biol VL - 9 UR - https://doi.org/10.1088/1478-3975/9/5/055001 DO - 10.1088/1478-3975/9/5/055001 ID - Wang2012 ER - TY - JOUR AU - Werner, H. M. J. AU - Mills, G. B. AU - Ram, P. T. PY - 2014 DA - 2014// TI - Cancer systems biology: a peek into the future of patient care? JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.6 DO - 10.1038/nrclinonc.2014.6 ID - Werner2014 ER - TY - JOUR AU - Will, M. AU - Qin, A. C. R. AU - Toy, W. AU - Yao, Z. AU - Rodrik-Outmezguine, V. AU - Schneider, C. PY - 2014 DA - 2014// TI - Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS-ERK signaling JO - Cancer Discov. VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-13-0611 DO - 10.1158/2159-8290.CD-13-0611 ID - Will2014 ER - TY - STD TI - Zañudo JGT, Albert R. An effective network reduction approach to find the dynamical repertoire of discrete dynamic networks. Chaos. 2013;23(2). ID - ref78 ER - TY - JOUR AU - Zañudo, J. G. T. AU - Albert, R. PY - 2015 DA - 2015// TI - Cell fate reprogramming by control of intracellular network dynamics JO - PLoS Comput Biol VL - 11 UR - https://doi.org/10.1371/journal.pcbi.1004193 DO - 10.1371/journal.pcbi.1004193 ID - Zañudo2015 ER - TY - JOUR AU - Zehir, A. AU - Benayed, R. AU - Shah, R. H. AU - Syed, A. AU - Middha, S. AU - Kim, H. R. PY - 2017 DA - 2017// TI - Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients JO - Nat Med VL - 23 UR - https://doi.org/10.1038/nm.4333 DO - 10.1038/nm.4333 ID - Zehir2017 ER - TY - JOUR AU - Zhang, J. AU - Tian, X. -. J. AU - Zhang, H. AU - Teng, Y. AU - Li, R. AU - Bai, F. PY - 2014 DA - 2014// TI - TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops JO - Sci Signal VL - 7 UR - https://doi.org/10.1126/scisignal.2005304 DO - 10.1126/scisignal.2005304 ID - Zhang2014 ER - TY - JOUR AU - Zhang, S. AU - Huang, W. -. C. AU - Li, P. AU - Guo, H. AU - Poh, S. -. B. AU - Brady, S. W. PY - 2011 DA - 2011// TI - Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways JO - Nat Med VL - 17 UR - https://doi.org/10.1038/nm.2309 DO - 10.1038/nm.2309 ID - Zhang2011 ER - TY - JOUR AU - Zhang, Y. AU - Kwok-Shing Ng, P. AU - Kucherlapati, M. AU - Chen, F. AU - Liu, Y. AU - Tsang, Y. H. PY - 2017 DA - 2017// TI - A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations JO - Cancer Cell VL - 31 UR - https://doi.org/10.1016/j.ccell.2017.04.013 DO - 10.1016/j.ccell.2017.04.013 ID - Zhang2017 ER - TY - JOUR AU - Zwang, Y. AU - Jonas, O. AU - Chen, C. AU - Rinne, M. L. AU - Doench, J. G. AU - Piccioni, F. PY - 2017 DA - 2017// TI - Synergistic interactions with PI3K inhibition that induce apoptosis JO - elife VL - 6 UR - https://doi.org/10.7554/eLife.24523 DO - 10.7554/eLife.24523 ID - Zwang2017 ER -